{HEAD ~ The method} 1 wherein {TAIL ~ the anti diabetic agent} is selected from the group consisting of a sulfonylurea, a meglitinide, an agents which modify insulin secretion, a biguanide, a thiazolidinedione, a peroxisome proliferator activated receptor gamma agonist , a Retinoid X receptor modulator, an insulin sensitizing agent, an alpha glucosidase inhibitor, an insulin, a small molecule mimics of insulin, 
wherein
{ HEAD ~ The method } 1 wherein { TAIL ~ the anti diabetic agent } is selected from the group consisting of a sulfonylurea , a meglitinide , an agents which modify insulin secretion , a biguanide , a thiazolidinedione , a peroxisome proliferator activated receptor gamma agonist , a Retinoid X receptor modulator , an insulin sensitizing agent , an alpha glucosidase inhibitor , an insulin , a small molecule mimics of insulin ,
HEAD HEAD HEAD HEAD HEAD HEAD OTH REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH